# Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

> **NCT06929468** · — · NOT_YET_RECRUITING · sponsor: **Simon Jäger** · enrollment: 55 (estimated)

## Conditions studied

- Ototoxic Hearing Loss
- Ototoxicity, Drug-Induced
- Cisplatin-induced Hearing Loss
- Cisplatin Ototoxicity
- Head and Neck Cancer
- Dizzyness
- Inner Ear Hearing Loss
- Vestibular Disease
- Squamous Cell Carcinoma of the Head and Neck
- Deafness
- Hearing Loss

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06929468
- **Lead sponsor:** Simon Jäger
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2025-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06929468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06929468, "Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06929468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*